NEW YORK, United States, 2023-Oct-16 — /EPR Network/ — “According to the research report published by Polaris Market Research, the Global Cancer Immunotherapy Market Size [… Read More
The global non-small cell lung cancer (NSCLC) treatment market is estimated to be valued at US$ 24,910.7 million in 2022 and is expected to exhibit a CAGR of 9.4% over the forecast period 20… Read More
Radiopharmaceuticals are an emerging and promising approach for diagnosing and treating various types of cancer. Radiopharmaceutical therapy (RPT) has demonstrated effectiveness with minimal… Read More
MedPage Today brought together three expert leaders for a virtual roundtable discussion on lung cancer: Moderator Roy Herbst, MD, PhD, is joined by Anne Chiang, MD, PhD, and So Yeon Kim, M… Read More
Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, w… Read More
The global CAR T Cell Therapy Market is estimated to be valued at US$ 2.26 Billion in 2022 and is expected to exhibit a CAGR of 20.9% over the forecast period 2022-2030, as highlighted in a… Read More
Zhen Xu, Ph.D., invented histotripsy « Tumor-destroying soundwaves receive FDA approval for liver treatment in humans. Photo Credit: University of Michigan via NewswiseMega Doctor News… Read More
Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appo… Read More
Introduction:
In the ever-evolving landscape of medical technology, the Radiotherapy Market has emerged as a pivotal player, transforming the way cancer treatments are administered. With… Read More
Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, i… Read More
According to the TechSci Research report titled “United States Ovarian Cancer Therapeutics Market – By Region, Competition Forecast and Opportunities, 2018-2028,” the Unite… Read More
Over the past decade, significant strides have been made in the realm of peptide drug development courtesy of ground-breaking advancements in produc… Read More
The therapeutic areas of clinical research guide researchers, physicians, and biopharma companies in pursuing improved healthcare interventions and patient outcomes. The most common therapeu… Read More
Healthcare companies are always on the lookout to improve outcomes in the healthcare system and consolidate the healthcare industry. Healthcare providers offer essential services and game-ch… Read More
The total size of the immunotherapy drugs market will propel at a rate of 7.10% by the end of this decade, to touch USD 210,752 million by 2030.
Globally, chronic diseases are a major p… Read More